ArticleBMC oral health2025
Evaluation of salivary Ki-67 in health and periodontitis.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic and Epigenetic Biomarkers for the Early Oral Cancerization Risk in Periodontitis Patients.Current issues in molecular biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundKi-67, a nuclear protein is found in cells undergoing proliferation during the cell cycle. It has been established as an important tumor proliferation and prognostic marker. An increased expression of Ki-67 is observed in inflammation. Periodontitis tissue biopsy specimens have shown Ki-67 expression. Saliva has become popular as a non-invasive source of biomarkers that may have a clinical utility. Ki-67 has not been examined in the saliva of patients having periodontitis. This cross-sectional study aimed to detect and make a comparative estimation of salivary Ki-67 in health and periodontitis.
methodsFifty-two participants were divided equally into two groups: Health [systemically and periodontally healthy (n = 26)] and Periodontitis [systemically healthy periodontitis patients (n = 26)]. Study volunteers were recruited based on the selection criteria. Plaque index, modified gingival index, bleeding on probing, probing pocket depth and clinical attachment loss were recorded. Saliva was obtained and Ki-67 was estimated with a commercially available ELISA kit.
resultsThe periodontitis group had significantly higher levels of Ki-67 than the healthy group. Overall, except with plaque index, there were significant positive weak correlations between Ki-67 and modified gingival index, bleeding on probing, probing pocket depth, and significant positive strong correlation with clinical attachment loss. Receiver operating characteristic analysis of the diagnostic accuracy of Ki-67 in periodontitis showed that the area under the curve was statistically significant, and the cutoff value was > 787.67 pg/ml.
conclusionKi-67 can be detected in saliva and has a role in periodontitis. This implies that saliva can be a non-invasive source for Ki-67 as a potential biomarker in periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.